Introduction Choosing a treatment for lymphoma is not just about medical outcomes. It is also about time, access, readiness, and what is realistically possible for a patient and their family. With newer therapies entering the picture, patients are often faced with options that sound promising but feel difficult to compare. This piece looks at two such treatments and explores how they differ when it comes to access and availability, helping patients and caregivers think through what each option may mean in real life. Overview of Columvi and How It Works Columvi ( glofitamab gxbm ) is a prescription medication used to treat adults with certain types of large B cell lymphoma, including diffuse large B cell lymphoma, whose disease has returned or did not respond to earlier treatments, after they have already received two or more prior cancer therapies. 1 Columvi is a bispecific monoclonal antibody, which means it is designed to attach to two...